TrialPsychiatry and clinical neurosciences2021

Cost-effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy-resistant depression at secondary mental health care settings.

Mitsuhiro Sado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.